Delivery Order SPE2DX22D0019-SPE2D826FCE84
- Not listed
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $77,859.60 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026. The firm fixed-price contract, which carries no set-aside designation, has an ultimate completion date of January 7, 2026 and will be performed in Conshohocken, Pennsylvania, where the company maintains its corporate office. This delivery order represents a task order under a larger contracting vehicle and...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $7,785.54 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price, non-set-aside contract is a child order under a larger Indefinite Delivery Contract vehicle with a ceiling value of $999,999,999.00 that runs through December 2026. The delivery order is scheduled for completion by January 7, 2026, with performance occurring at the company's corporate office...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order contract valued at $1,074.78 by the Defense Logistics Agency Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order, which utilizes no set-aside designation, represents a task order under a larger Indefinite Delivery Contract vehicle. The work will be performed at the company's corporate office location in Conshohocken, Pennsylvania....
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $31,173.60 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price contract was competitively awarded with no set-aside designation and will be performed at the company's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order issued under Amerisourcebergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $1,359.62 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside contract is expected to reach completion by January 7, 2026, with performance occurring at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The delivery order represents a task order under Amerisourcebergen's broader Indefinite Delivery...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a $74,044.06 firm fixed-price delivery order by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This non-set-aside, competitively awarded contract represents a single delivery order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical valued at up to $999,999,999.00 through December 2026. The work will be...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $116,789.40 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, which is not set aside for any specific business type, has an ultimate completion date of January 7, 2026, and represents a task order under Amerisourcebergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is Conshohocken,...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $27,807 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a task order under a larger indefinite delivery contract vehicle. The award is part of AmerisourceBergen's...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $15,345.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with an ultimate completion date of January 7, 2026. This firm fixed-price, non-set-aside contract represents a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The contract will be performed at the...
- Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $24,552.00 by the Defense Logistics Agency's Medical Supply Chain on January 6, 2026, with completion expected by January 7, 2026. This firm fixed-price delivery order was issued on a non-competitive, non-set-aside basis and will be performed at the company's corporate office in Conshohocken, Pennsylvania. The award represents a task order issued under Amerisourcebergen's larger Indefinite Delivery...
- SPE2DX22D0019Indefinite Delivery Contract
- SPE2DX22D0019-SPE2D826FCE84Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was awarded a delivery order valued at $14,865.12 on January 6, 2026, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price, non-set-aside delivery order is scheduled for completion by January 7, 2026, with performance taking place at the company's Corporate Office location in Conshohocken, Pennsylvania. The award represents a task order issued under a larger contracting vehicle supporting federal pharmaceutical and medical supply procurement. Amerisourcebergen Drug Corp serves as a critical pharmaceutical distributor for federal military and veteran healthcare systems through its parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2026. The broader contract vehicle enables the company to supply comprehensive pharmaceutical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices across multiple therapeutic domains to support military healthcare programs globally. This delivery order reflects the company's established capability and capacity to meet federal procurement requirements through open competition in pharmaceutical and medical supply distribution.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $14.9k | 1/5/26 |